Summary 415 million people live with diabetes worldwide, and an estimated 193 million
people have undiagnosed diabetes. Type 2 diabetes accounts for more than 90% of patients …

Glycated hemoglobin A1c (HbA1c) is routinely used as a marker of average glycemic
control, but it fails to provide data on hypoglycemia and glycemic variability, both of which …

Aims Randomised controlled trials demonstrate that using flash glucose monitoring
improves glycaemic control but it is unclear whether this applies outside trial conditions. We …

OBJECTIVE Appropriate glycemic control is fundamental to diabetes care, but aggressive
glucose targets and intensive therapy may unintentionally increase episodes of …

Cardiovascular disease remains the main cause of morbidity and mortality in patients with
diabetes. The risk of vascular ischemia is increased in this population and outcome …

Objective Observations in real-world settings support and extend findings demonstrated in
randomized controlled trials that show flash glucose monitoring improves glycemic control …

OBJECTIVE To analyze the impact of modern glucose-monitoring strategies on glycemic
and patient-related outcomes in individuals with type 2 diabetes (T2D) and recent …

Controlling glycemia in diabetes remains key to prevent complications in this condition.
However, glucose levels can undergo large fluctuations secondary to daily activities …

In the century since the discovery of insulin, diabetes has changed from an early death
sentence to a manageable chronic disease. This change in longevity and duration of …

Background Hypoglycaemia has been linked to an increased risk of cardiac arrhythmias by
causing autonomic and metabolic alterations, which may be associated with detrimental …